Minutes from the Extraordinary General Meeting 7 November 2016
(Oslo, Norway, 8 November 2016) The Extraordinary General Meeting of Bionor Pharma ASA (OSE:BIONOR) yesterday adopted all items and resolutions as proposed in the notice.
STOCK EXCHANGE ANNOUNCEMENT
The Extraordinary General Meeting approved the board authorization to increase the share capital.
This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
Unni Hjelmaas, Acting CEO, +47 915 19 651, email@example.com
Jens Krøis, CFO, +45 20 80 16 68, firstname.lastname@example.org
Link for announcement in pdf
Minutes in pdf